On-Demand Cell Line Development Webinars

  1. A Robust And Scalable Suspension Platform For AAV Manufacturing

    Review the demands for AAV manufacturing using a suspension process and the DOE-based strategy used to achieve a scalable process both in terms production and quality of AAV purified.

  2. De-Risk Your Path To Clinic With An AAV Suspension Platform

    Build a reliable, de-risked path to the clinic while avoiding unforeseen costs and compliance-related delays with advice from Suparna Sanyal, PhD, Head of Viral Vectors Commercial Development.

  3. Overcoming The Challenges In Fabs And Fc-Fusion Development Programs

    Explore an integrated drug substance and drug product CMC strategy, along with technical case studies from process and analytical development that provide insight into tailored product-specific solutions.

  4. Bridging The Gap Between mAbs And Next-Generation Therapeutics

    Review the Apollo™ X expression system's ability to express bispecific and Fc-fusion molecules efficiently through a streamlined development process.

  5. Improved Design And Production Of Bispecific Therapeutics

    See how bispecific pairing technology uses a close-to-nature design solution to deliver highly accurate heavy-light chain pairing efficiencies and improved manufacturability.

  6. Continuous Manufacturing: Challenges, Advantages Of N-1 Perfusion

    Discover key considerations and challenges in implementing N-1 perfusion technology, as well as the impact of continuous technology on tech transfer and process scale-up.

  7. Precision Execution Of Bispecifics At Scale From Design To Delivery

    Explore a new technology that promotes highly efficient heavy-light chain dimerization, and case studies where this technology and other tools can be combined to improve bsAb expression.

  8. Expressing Next-Gen Immunotherapies And Other Advanced Biologics

    Explore how the GS Gene Expression System and cell line engineering technology can rise to the challenge of producing novel IgG-engineered cancer immunotherapies.

  9. Hybrid Approach For Optimizing Transient Protein Expression In CHO Cells

    Review the details of an optimized transient expression system that offers a ‘hybrid’ approach for boosting titres of a wide range of molecules.